Lycopodium Limited
Investment Thesis
The Business
Lycopodium designs, procures, and manages the construction of mineral processing plants, primarily for gold miners. It operates through four geographic divisions: Asia-Pacific (APAC), which has historically been the core; Africa, where major gold projects drive episodic but large contract awards; Americas, which expanded sharply with the 2025 acquisition of SAXUM; and a smaller Industrial division covering process industries. The company earns fees for engineering studies, front-end engineering design (FEED), and full engineering, procurement, and construction management (EPCM) contracts. It owns almost no physical assets, which means capital requirements are minimal and cash conversion is high.
Recent Performance
The stock has re-rated materially over the past two years, driven by surging gold prices and a record pipeline of project announcements. Revenue dipped 3% in FY25 to $340 million as major APAC projects wound down, but NPAT held at $42 million and the company paid a fully franked 50 cent dividend. The SAXUM acquisition, completed in late FY25, transformed the Americas division from a minor contributor into a meaningful revenue source, setting up a sharp revenue step-up in FY26. The first half of FY26 validated the SAXUM thesis in revenue terms, with the Americas division delivering a 20.6% PBT margin above the group average, which had been the key uncertainty heading into the integration.
Outlook
Revenue is expected to grow materially in FY26, largely reflecting SAXUM's first full year of consolidation, with the Americas division scaling from $55 million in FY25 to an estimated $125 million in FY26. Africa accelerates as the Doropo EPCM contract in Côte d'Ivoire ramps through late 2026. The EBITDA margin compresses from around 20% toward 17% as SAXUM's construction-weighted contracts sit at lower margins than Lycopodium's legacy EPCM work. This is mix-shift rather than operational deterioration, and absolute EBITDA dollars continue to grow as revenue scales. Management has guided to full-year FY26 NPAT of $37-41 million, weighted toward the second half.
Key Risks
Gold price reversion is the primary threat. Gold currently drives over 60% of the project pipeline, and a sustained move below $3,000 per ounce would compress project sanctions and slow pipeline replenishment within 12-18 months. The $415 million committed order book provides a buffer, but new contract flow would slow materially before the existing backlog is exhausted. SAXUM's margin trajectory is the single most sensitive variable in any earnings model: the 20.6% Americas PBT margin seen in the first half of FY26 reflects early project stages where engineering fees dominate, and the picture as construction volumes ramp will determine whether the current margin is structural or a high-water mark. Project timing risk is structural to the EPCM model and cannot be fully diversified away. Tulu Kapi in Ethiopia has already experienced regulatory delays, and Blackwater in Queensland has seen timing shifts; a client deferring or cancelling a project after FEED completion can remove $20-50 million of forward revenue with minimal notice.
What to Watch
The thesis-defining event is the FY26 full-year result in August 2026, which will reveal whether SAXUM Americas is sustaining its first-half PBT margin as construction volumes ramp, or whether that figure compressed through the second half. The Doropo EPCM ramp in Africa is the second key monitor: revenue should accelerate as the Côte d'Ivoire project moves from mobilisation into full engineering through Q4 2026. The February 2027 half-year result will provide the first full-year view of SAXUM at scale, which is the data point that resolves the terminal margin question.
- August 2026 FY26 results and FY27 guidance — confirms margin trajectory and order book momentum. The key question is whether Americas PBT margin held above 18% through the construction-weighted second half.
- Q4 2026 Doropo EPCM ramp — Africa revenue accelerates as the $196 million Côte d'Ivoire project moves from mobilisation into full engineering. This is the primary driver of FY27 Africa divisional growth.
- February 2027 SAXUM full-year margin clarity (1H FY27) — the most consequential data point for calibrating the long-run margin assumption. Two consecutive halves above 18% Americas PBT margin would suggest the terminal EBITDA margin modelled at 16% is conservative.
Business Quality
Company Description
Lycopodium provides engineering, procurement, and construction management (EPCM) services for mineral processing plants, with gold accounting for roughly 60% of its pipeline. The company operates from four geographic divisions. APAC generated $245 million in FY25 and represents the historical core, built on Australian-based EPCM expertise and a Manila engineering centre that provides cost-competitive offshore labour. Africa contributed $28 million in FY25 but is accelerating sharply with Doropo, Tulu Kapi, and other major gold projects moving to construction. Americas grew to $55 million in FY25 before the SAXUM acquisition transformed it, and is now the fastest-growing division at a forecast $125 million in FY26. An Industrial division covering infrastructure and process industries contributes approximately $25 million and provides some non-gold diversification.
Where the Growth Is
The Americas division, operating through SAXUM, is where the next two years of earnings growth will be concentrated. SAXUM contributes approximately $125 million in FY26 revenue, representing around 32% of group revenue, scaling toward $140 million by FY27. Beyond revenue volume, SAXUM brings exposure to copper, lithium, and cement projects, which will reduce gold concentration from roughly 60% today toward 45% over three years. The acquisition carries a put/call structure on the remaining 40% stake, giving management a defined path to full ownership if integration performs.
Competitive Position
Lycopodium's competitive position rests on three compounding advantages. First, a 30-year track record specifically in gold plant EPCM, with repeat clients including Newmont, Perseus, and Resolute: credentials that take decades to build and cannot be replicated by a new entrant. Second, the study-to-EPCM pipeline: the company frequently performs feasibility studies and FEED work before a project is sanctioned, and converts roughly half of those studies into full EPCM mandates. This creates two to three years of revenue visibility and makes switching to a competitor expensive for clients already invested in Lycopodium's designs. Third, the Manila engineering centre provides structurally lower cost delivery versus Perth or Sydney-based peers.
These advantages are stable rather than widening. The moat does not deepen automatically, and the competitive position requires continuous execution to sustain. In a capacity-constrained market with gold at record levels, the near-term pricing environment favours incumbents, but that condition is cyclical rather than permanent.
Management and Capital Discipline
Peter De Leo's management team has a consistent track record of guidance delivery, hitting or exceeding targets in FY25 and tracking to the upper end of FY26's $37-41 million NPAT guidance range. Capital allocation has been disciplined: SAXUM was acquired with a put/call exit structure on the remaining 40% minority stake, the payout ratio is being stepped up from 47% to 55% as earnings mature, and the company has accumulated $76 million in net cash without taking on debt.
The one honest observation worth making is that management leaves SAXUM's margin trajectory deliberately vague in communications, despite it being the single most important variable for long-run earnings. Investors cannot independently calibrate whether the 20.6% Americas PBT margin seen in the first half of FY26 is structural or a high-water mark. That opacity is a minor blemish on an otherwise transparent management record, and it is the primary reason the February 2027 half-year result carries such analytical weight.
Financial Position
Lycopodium carries $76 million in net cash, zero financial debt, and lease liabilities of $14 million under IFRS 16 accounting rules. Free cash flow is expected to grow from approximately $41 million in FY26 toward $53 million by FY28, and the company's capital requirements are minimal at roughly 0.8% of revenue in maintenance capex. This balance sheet can comfortably absorb a multi-year downturn in project activity without capital raising or covenant stress. The net cash position also funds the SAXUM put/call option on the remaining 40% minority stake, which represents the most likely use of capital over the next two years. Returns on invested capital of approximately 30% are roughly double the cost of capital, confirming that the business generates genuine economic value rather than merely accounting profit.
Read the full report
Our complete analysis of Lycopodium Limited includes: